Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
2.650
-0.070 (-2.57%)
Mar 9, 2026, 4:00 PM EDT - Market closed
UPC Revenue
In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86M, down -22.44%. Universe Pharmaceuticals INC had revenue of $8.71M in the half year ending September 30, 2025, a decrease of -37.10%.
Revenue (ttm)
$17.86M
Revenue Growth
-22.44%
P/S Ratio
0.09
Revenue / Employee
$82,679
Employees
216
Market Cap
1.49M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 37.61M |
| Sunshine Biopharma | 37.32M |
| cbdMD | 19.09M |
| Sonoma Pharmaceuticals | 17.72M |
| RedHill Biopharma | 9.55M |
| InMed Pharmaceuticals | 4.51M |
| China Pharma Holdings | 4.05M |
| China SXT Pharmaceuticals | 1.54M |
UPC News
- 25 days ago - Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Announces Share Consolidation - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request - GlobeNewsWire
- 1 year ago - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 1 year ago - Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024 - GlobeNewsWire
- 2 years ago - Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results - PRNewsWire